Technical Analysis for MKKGY - Merck Kgaa ADR

Grade Last Price % Change Price Change
grade A 23.69 0.21% 0.0500
MKKGY closed up 0.21 percent on Friday, October 18, 2019, on 1.17 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MKKGY trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%

Older signals for MKKGY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, multiple sclerosis, and colorectal cancer, as well as carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. It also provides over-the counter and food supplement products under the Neurobion, Bion3, Seven Seas, Nasivin, Femibion, Dolo-Neurobion, Vivera/Floratil, Sangobion, Vigantoletten, Apaisyl, and Kytta brands. In addition, the company offers life science products and services for use in the discovery, development, and manufacture of biotechnological drugs, as well as in laboratories; and specialty chemicals and functional materials for use in consumer electronics, lighting, coatings, printing technology, paints, plastics, and cosmetics. It has strategic alliances with Pfizer Inc., Baylor College of Medicine, Bristol-Myers Squibb Company, Intrexon Corporation, F-star Delta Ltd, Alibaba Health, and Checkmate Pharmaceuticals. The company also has collaboration with the Solvias to offer the PyroMAT system, a MAT kit for pyrogen detection; Immutep Limited; Leap Therapeutics, Inc.; and Personal Genome Diagnostics Inc. In addition, MERCK Kommanditgesellschaft auf Aktien has a collaboration with Daiichi Sankyo Company, Limited to evaluate the combination of DS-8201, an investigational HER2 targeting antibody drug conjugate; and a strategic alliance with genOway S.A. to develop CRISPR/Cas9-related products and solutions, as well as with GSK to develop and commercialize M7824, which is in Phase II trial for treating patients with PD-L1 expressing non-small cell lung cancer. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Health Healthcare Chemicals Pharmaceutical Industry Plastics Diabetes Pharmaceutical Industry In China Consumer Electronics Multiple Sclerosis Colorectal Cancer Non Small Cell Lung Cancer Allergen Immunotherapy Infertility Merck Carcinoma Immutep Life Science Products
Is MKKGY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.69
52 Week Low 19.2
Average Volume 9,803
200-Day Moving Average 21.3814
50-Day Moving Average 21.8833
20-Day Moving Average 22.6927
10-Day Moving Average 22.99
Average True Range 0.2699
ADX 26.95
+DI 51.511
-DI 17.6978
Chandelier Exit (Long, 3 ATRs ) 22.8803
Chandelier Exit (Short, 3 ATRs ) 22.6297
Upper Bollinger Band 23.6524
Lower Bollinger Band 21.733
Percent B (%b) 1.02
BandWidth 8.458227
MACD Line 0.4406
MACD Signal Line 0.3494
MACD Histogram 0.0912
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.9450
Resistance 3 (R3) 23.9167 23.8033 23.9025
Resistance 2 (R2) 23.8033 23.7384 23.8175 23.8883
Resistance 1 (R1) 23.7467 23.6983 23.7750 23.7750 23.8742
Pivot Point 23.6333 23.6333 23.6475 23.6475 23.6333
Support 1 (S1) 23.5767 23.5684 23.6050 23.6050 23.5058
Support 2 (S2) 23.4633 23.5283 23.4775 23.4917
Support 3 (S3) 23.4067 23.4633 23.4775
Support 4 (S4) 23.4350